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Abstract 
The stage and severity of Parkinson's disease (PD) is an important factor to consider for taking 
effective therapeutic decisions. Although the Movement Disorder Society-Unified Parkinson's 
Disease Rating Scale (MDS-UPDRS) provides an effective instrument evaluating the most 
pertinent features of PD, it does not allow PD staging. On the other hand, the Hoehn and Yahr 
(HY) scale which provides staging, does not evaluate many relevant features of PD. In this 
paper, we propose a novel and improved staging for PD using the MDS-UPDRS features and the 
HY scale, and developing prediction models to estimate the stage (normal, early or moderate) 
and severity of PD using machine learning techniques such as ordinal logistic regression (OLR), 
support vector machine (SVM), AdaBoost- and RUSBoost-based classifiers. Along with this, 
feature importance in PD is also estimated using Random forests. We observe that the predictive 
models of SVM, Adaboost-based ensemble, Random forests and probabilistic generative model 
performed well with the AdaBoost-based ensemble giving the highest accuracy of 97.46%. Body 
bradykinesia, tremor, facial expression (hypomimia), constancy of rest tremor and handwriting 
(micrographia) were observed to be the most important features in PD. It is inferred that MDS-
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 UPDRS combined with classifiers can form effective tools to predict PD staging which can aid 
clinicians in the diagnostic process. 
Keywords: Parkinson's disease (PD), Computer-aided diagnosis, Medical expert systems, 
Predictive models, Machine learning 
1. Introduction 
Parkinson's Disease (PD) is a progressive neurodegenerative disorder characterized by a number 
of motor and non-motor features resulting in a marked reduction in quality of life [1]. It is 
characterized by the degeneration of dopaminergic neurons in the substantia nigra pars compacta 
resulting in a substantial reduction of striatal dopamine. This dopamine deficiency causes a 
variety of symptoms, among which the four cardinal motor features are: tremor at rest, rigidity, 
bradykinesia and postural instability [1, 2]. These symptoms begin insidiously, usually affecting 
one side of the body before spreading to the other, and gradually worsen, and if untreated, the 
symptoms lead to disability with severe immobility and falling [1, 3]. Presently, PD is an 
incurable condition, and the therapeutic options mainly focus on symptomatic relief.  
Stage and severity of PD is important to estimate for taking effective decisions related to therapy. 
For instance, Rascol et al. [4] observed that early stage PD can be managed successfully by 
initiating treatment with dopamine agonists such as ropinirole alone, rather than starting with 
levodopa (which is the most potent and effective medication in PD). Drugs such as Monoamine 
oxidase B (MAO-B) inhibitors have shown to delay the need for levodopa in early PD and have 
been approved for use in later stages of PD to boost the effects of levodopa. Other drugs such as 
amantadine can help in early PD for treating tremor and also in late PD by reducing dyskinesias 
that may occur with levodopa or dopamine agonists  
 (http://www.pdf.org/pdf/fs_understanding_medications_12.pdf). 
There are many scales to evaluate impairment and disability (stage and severity) in PD. Among 
these, the Unified Parkinson's Disease Rating Scale (UPDRS) and the Hoehn and Yahr (HY) 
scale are the most commonly used [2]. UPDRS provides a comprehensive assessment of 
disability and impairment by evaluating the most pertinent clinical features of PD [5], whereas 
the HY scale provides a gross assessment of disease progression through a staging which ranges 
from 0 (no sign of disease) to 5 (severe) [6]. The Movement Disorder Society-Unified 
Parkinson's Disease Rating Scale (MDS-UPDRS) [5] is the updated and revised version of the 
original UPDRS with new items devoted to several non-motor elements of PD (thus, making it 
more comprehensive than the original scale). Other important differences include refined scoring 
instructions and definitions, and emphasis on impairments and disabilities related to milder 
symptoms and signs [5]. A brief description of MDS-UPDRS and HY scales are given below: 
1.1 MDS-UPDRS 
The MDS-UPDRS provides a comprehensive assessment of the clinical features (both motor as 
well as non-motor) of PD [5]. The scale consists of 65 items in 4 parts. Part I assesses the non-
motor experiences of daily living, and contains 13 items evaluated partly (the first 6 items) by a 
specialist and partly (the next 7 items) as a patient questionnaire. Part II concerns motor 
experiences of daily living, and contains 13 items evaluated completely as a patient 
questionnaire. Part III is motor examination, containing 33 items and evaluated completely by a 
specialist. Part IV assesses motor complications, containing 6 items and evaluated by a specialist 
once a PD subject has started PD medication. Part IV assesses two motor complications: 
 dyskinesias and motor fluctuations which are strongly related to the duration of disease, 
levodopa dose and the duration of levodopa treatment [7]. 
Before MDS-UPDRS, the original UPDRS was used as a gold standard for PD evaluation [8]. 
UPDRS has shown strong correlations with HY stages and has displayed excellent internal 
consistency across different HY stages [8]. Longitudinal studies show that UPDRS scores 
increase over time, and that the scores can indicate crucial clinical decision-making points like 
the need to introduce symptomatic therapy [8, 9]. However, the original UPDRS had few 
shortcomings that it did not cover the full spectrum of PD (especially the non-motor aspects of 
PD), and that the scale favored moderate to late PD, than mild or early PD [8]. Validation studies 
on the MDS-UPDRS have shown that the updated scale strongly correlated with the original 
UPDRS, and significantly correlated with other disability measures, quality of life scales and 
disease duration [5, 10-13]. It is also shown that MDS-UPDRS is more sensitive to changes in 
PD than the original version [14]. These studies show that the MDS-UPDRS provides a wide 
spectrum of assessments, and is a reliable and sensitive instrument for estimating the progression 
and severity in PD. 
1.2 Hoehn and Yahr (HY) Scale 
The HY scale is another widely-used scale to assess PD severity. The scale provides an overall 
assessment of severity through staging. The progression of PD usually starts from unilateral 
(Stage 1), to bilateral without balance difficulties (Stage 2), followed by the presence of postural 
instability (Stage 3), to loss of physical independence (Stage 4), and being wheel-chair or bed-
bound unless aided (Stage 5). 
 The HY scale has also been used to categorize PD as early stage (Stage 1 and 2), moderate stage 
(Stage 3) and late stage (Stages 4 and 5). Studies have shown that stage has a significant 
correlation with quality of life measures, and a high correlation with the UPDRS [6]. 
Neuroimaging studies also indicate that progressively higher stages correlate well with 
dopaminergic loss [15]. These studies support the utility of HY scale to categorize PD subjects 
based on the severity. 
1.3 Motivation, Background and Scope of the study 
Although the MDS-UPDRS evaluates the most pertinent features of PD, it does not perform 
staging. On the other hand, the HY scale provides staging of PD, but does not evaluate many 
pertinent features. HY staging is usually performed using a 'rate-as-you-see' approach, taking 
into account all clinical impairments seen, regardless of their direct relationship to PD [6], and is 
often biased by the experience of the physician completing the scale. This makes it susceptible to 
inter-rater variability.  
There have been attempts to relate UPDRS and HY [16-18]. Scanlon et al. [16, 17] proposed 
formulas to obtain HY stages from UPDRS Part III scores. Tsanas et al. [18] optimized this 
formula by refining its parameters using genetic algorithm (GA). However, these studies had two 
shortcomings: 1) the formula was based on intuitive rules, and 2) they used only Part III (motor 
examination) of the UPDRS, and did not make use of the full spectrum of pertinent PD features. 
In this work, for the first time, we propose an improved way of PD staging using MDS-UPDRS, 
HY scale and machine learning. We use all the features from Parts I, II and III of the MDS-
UPDRS, as obtained from the Parkinson's Progression Markers Initiative (PPMI) database [19] 
to develop diagnostic models to estimate the stage (normal stage, early stage and moderate stage) 
 and severity of PD. Along with this, we also estimate the importance of these features in PD. We 
did not use Part IV in the study as this part mainly focuses on the complications from long-term 
treatment for PD, and the PPMI database consisted majority of patients who were in their early 
stages and they have not undergone long term treatments or were showing these complications. 
2. Materials and Methods 
2.1 Database 
Data used in the preparation of this article were obtained from the Parkinson's Progression 
Markers Initiative (PPMI) database. For up-to-date information on the study, please visit 
http://www.ppmi-info.org. PPMI is a landmark, large-scale, comprehensive, observational, 
international, and multicenter study to identify PD progression biomarkers. For the study, we 
considered the features from Parts I, II and III of the MDS-UPDRS, making a total number of 
features as 59. Part IV was not used as it assesses motor complications of dyskinesias and motor 
fluctuations that are mostly shown by advanced stage PD patients. As our dataset focused on 
early and moderate PD, this part was not considered. The study dataset includes observations 
from the same time periods (visits) for both healthy control (HC) and Parkinson’s disease (PD) 
patients.  
2.2 Cohort Details 
The data used in the study were from the same time instances, rather than taking the complete set 
of observations for the sake of removing any bias, and accordingly it contained MDS-UPDRS 
scores collected for Month 0 (Baseline or BL), Month 12 (Visit 04 or V04), Month 24 (Visit 06 
or V06), Month 36 (Visit 08 or V08), Month 48 (Visit 10 or V10), Month 60 (Visit 12 or V12) 
and Month 84 (Visit 14 or V14) from age and gender matched PD and HC subjects.  
 The data contains 1025 observations from 197 HC subjects and 1995 observations from 434 PD 
subjects, making a total of 3020 observations from 631 subjects. Table 1 shows the number of 
subjects and their mean age at enrollment based on the gender for the healthy control (HC) and 
Parkinson’ disease (PD) groups. The PPMI has collected data from age and gender matched 
healthy control and de novo PD subjects. We can observe in the below table the same pattern that 
both the groups are age and gender matched. 
Table 1: Number of subjects and age at enrollment for HC and PD 
 No. of Subjects Age at Enrollment* 
Gender HC PD HC (in yrs) PD (in yrs) 
Female 71 149 59.37 ± 11.70 60.64 ± 9.61 
Male 126 285 61.78 ± 10.83 62.19 ± 9.69 
Total 197 434  
* HC and PD represent healthy control and Parkinson’s disease, respectively. The age at 
enrollment details for 3 HC and 7 PD subjects were not available. 
Table 2 shows the distribution of subjects with history of PD. Here, family history includes first 
degree relatives (biological parents, full siblings, and children) and second-degree relatives 
(maternal and paternal grandparents, maternal and paternal aunts and uncles, and half siblings). It 
is observed that 10 PD subjects showed a positive history of PD. But it is to be noted that for all 
these 10 subjects, the history corresponded to the second-degree relatives and none corresponded 
to the first-degree relatives. For the PD case, the history involved both first and second-order 
relatives.  
 Table 3 shows the number of subjects on medication and total number of subjects for different 
visits. There were no subjects who were on medication at BL visit. The medications used were 
Levodopa or Dopamine agonist or others. For subjects taking medication, as per the PPMI 
protocols, they have full MDS-UPDRS assessed off medication, followed by repeat Part III 
motor exam one hour after dosing in clinic. For predictive modelling, we have used the data 
taken before medication only. Fig.1 shown below shows the average of Part III scores pre and 
post medication. 
Table 2: Details of family history of the subjects 
 No. of Subjects 
History HC PD 
0 187 326 
1 10 107 
* History of 0 and 1 represent not having history and having history, respectively. Family history 
of one PD subject was not available. 
Table 3: Number of subjects on medication and total number of subjects for different visits 
 No. of Subjects  
Visit On med Total %age 
V04 212 348 60.92% 
V06 283 332 85.24% 
V08 305 329 92.71% 
V10 290 304 95.39% 
 V12 222 234 94.87% 
V14 15 15 100.00% 
 
 
Fig. 1. Mean of all total scores of MDS-UPDRS Part III for different visits for pre and post 
medication. The visit at month 84 (V14) was not included in the plot as the number of 
observations for V14 was very low.  
Table 4 shows the duration of PD at enrollment for both HC and PD subjects. At enrollment, all 
subjects were in their early and untreated stage or without medication. Table 5 shows the 
distribution of subjects for HC and PD based on a particular visit and severity as indicated by the 
Hoehn and Yahr (HY) stage. And for PD, the data used corresponded to the one that was 
 collected prior to the medication. It can be observed that 5 PD observations (from a total of 1995 
PD observations) showed severity of HY = 0. These observations although had a total of Parts I, 
II and III of MDS-UPDRS in the range 21 to 68 with mean as 39.40 ± 18.09 which is a value 
shown by PD subjects. It is to be noted that HY staging is usually performed using a 'rate-as-
you-see' approach making it susceptible to bias based on the clinician rating the subject. Along 
with this, it is to be noted that the number of subjects in V12 was much lower than the previous 
visits. This is because PPMI is a longitudinal study and the enrollment date of the subjects 
varied. A total of 111 subjects (32 Healthy control and 79 PD) had an enrollment date during 
2013 and their data for the V12 visit are yet to be updated in the PPMI database. 
Along with this, 16 HC observations (from a total of 1025 observations) showed severity of HY 
≠ 0. These observations had a total of Parts I, II and III of MDS-UPDRS in the range 3 to 35 
with mean as 12.88 ± 8.99. These observations might also be a possible case of bias from 
clinician, which is almost inevitable in large clinical trial study like PPMI, rating the subject.  
The change in severity is considered in the study. The severity of a considerable number of PD 
subjects changed during the course of the data collection. A total of 180 subjects showed a 
change in severity from HY stage 1 to 2, 35 subjects showed a change in severity from HY stage 
2 to 3, 3 subjects showed a severity change from HY stage 1 to stage 3, and 19 subjects showed a 
change in severity from 1 to 2 then 3. A low number of subjects whose severity changed from 
HY stage 1 to 3 indicate that during early stages of the disease, the progression might be mostly 
linear. 
 
 
 Table 4: Duration of PD at enrollment for HC and PD 
Gender Duration of PD at Enrollment (in months) 
Female 18.24 ± 19.16 
Male 16.29 ± 15.26 
* Duration of PD at Enrollment for 8 PD subjects was not available. 
Table 5: Distribution of subjects based on severity and visit 
Visit Group Hoehn & Yahr Stage Total 
  0 1 2 3  
BL HC 195 2   197 
PD  191 240 2 433 
V04 HC 177 3 4  184 
PD 1 101 234 12 348 
V06 HC 170 2 1  173 
PD 2 83 235 12 332 
V08 HC 164 1 1  166 
PD 1 62 244 22 329 
V10 HC 159 1 1  161 
PD 1 47 227 29 304 
V12 HC 132    132 
 PD  25 195 14 234 
V14 HC 12    12 
PD   13 2 15 
* BL data for one PD subject was not available 
Fig. 2 shows the stacked bar chart for all the 59 features for normal, early and moderate stage 
observations. Along with this, we have also shown plots that depicts the time development of all 
59 features in PD as well as HC in Fig. C1 (in Appendix). Fig. 3 shows the mean of all features 
for HC and PD groups as a stacked bar chart. It is clear from the graph that all features showed 
greater severity during PD. Among the features, the features 7 to 13 comparatively showed lower 
severity. This must be due to the fact that they represent the non-motor aspects of experiences in 
daily life and they were filled by the patient themselves. Studies have shown that age is a crucial 
factor for influencing non-motor features [20] and as the dataset involves mostly aged cohort, 
non-motor symptoms were more prevalent in the HC group.  
As observed from Table 5 (shown before) 191 subjects and 240 subjects were in HY stage 1 and 
2 respectively, combinedly making 431 subjects in early stage PD. Only 2 subjects were in 
moderate stage (HY stage 3) at baseline and this is because PPMI mainly focus on recruiting 
early PD subjects. 
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Fig. 2. The plot of severity of the features in MDS-UPDRS Parts I, II and III (a) Normal Stage 
(b) Early Stage, (c) Moderate stage 
 
Fig. 3. The plot of mean value of all features for HC and PD groups 
2.3 Statistical Analysis of features 
A flowchart of the proposed analysis is shown in Fig. 4. All the 59 features are analyzed for 
statistical significance. Features were selected based on filter methods. Statistical techniques of 
Kruskal-Wallis test for the 3-class classification problem (which was estimating the stage of a 
 subject) and Wilcoxon rank sum test for the 2-class problem (which was for estimating the 
feature importance). All the statistically significant features (p-value<0.05) are used for 
subsequent stage classification, severity and feature importance estimation. 
2.4 A note on imbalance in the dataset used 
The dataset used for the study was imbalanced with respect to normal stage (16.62%), and 
majorly imbalanced with respect to moderate stage PD (3.48%) as compared to early stage PD 
(79.90%). This imbalance is of extrinsic type where the imbalance is not directly related to the 
nature of data space [21]. The sample size of moderate stage PD subjects was small as PPMI 
(which is one of the large-scale studies in PD) had limited number of subjects who were at this 
stage.  
 
Fig. 4.  Flowchart for predictive modeling for novel and improved PD staging, and feature 
importance estimation. 
Fig. 2 shows that there is higher amount of class overlap between early and moderate stage PD, 
than between normal and early stage PD. In other words, there is higher class separability 
between the normal and early stage PD (which is more crucial), than between the early and 
 moderate stages. The data complexity arises due to small sample size of the moderate PD class, 
and the overlapping distributions between early PD and moderate PD classes. Therefore, it is 
evident that for this domain, we require a classifier that will provide a high overall accuracy, 
along with a high detection of the minority class (the moderate stage PD), without severely 
jeopardizing the accuracy of other classes (normal and early stage PD classes). 
2.5 Prediction modelling for PD severity and stage estimation 
The aim of this study is to estimate stage and severity in PD from the MDS-UPDRS ratings 
using HY scale for validation using prediction models. All the features that are statistically 
significant are used to develop prediction models. For our study, we use traditional as well as 
algorithms that are specific for multi-class imbalance problem.  
Cost-sensitive learning and sampling based methods dominate the current research in imbalanced 
data learning [21]. Sampling methods use resampling approaches to rebalance the class 
distribution, and cost-sensitive learning approaches involve biasing the minority class (by 
assigning higher misclassification costs for the minority class).  
For our experiments, we use ordinal logistic regression (as the response variable is ordinal), cost-
sensitive SVM [22], cost-sensitive AdaBoost-based ensemble [23, 24] and sampling based 
RUSBoost-based ensemble [25], k-nearest neighbor classifier [26], Random forests [27],  
probabilistic generative model [28] and neural networks [28] to perform prediction modelling. 
To estimate the optimal parameters for cost-sensitive and sampling based methods, we use the 
same approach as followed by Sun, Kamel, Wong and Wang [23, 29], where they use genetic 
algorithm (GA). We use LIBSVM library [30] for classification using SVM, and statistics and 
machine learning toolbox in MATLAB for classification using AdaBoost-based ensemble, 
 RUSBoost-based ensemble, Random forests, Probabilistic generative model, k-nearest neighbor 
and neural networks.  
The classification performances were evaluated based on a 10-fold cross validation setting that is 
repeated 100 times. The evaluation measures used are accuracy, precision, recall and F-measure 
(as described in Appendix A) which is computed for each class. Along with these, we also 
compute the Brier score for the logistic model, which is a well-known evaluation measure for 
probabilistic classifiers. 
Let the input data (or training data) be represented as 𝑆 = { 𝒙𝑖 ,𝑦𝑖 } where 𝒙𝑖  is an observation 
given by 𝒙𝑖 =  𝑥𝑖
 𝑗   ; 𝑗 = 1,… ,𝑚; 𝑖 = 1,… ,𝑛; m is the number of features and n is the number 
of observations. The response variable (or class label) be 𝑦𝑖 ;𝑦𝑖 ∈ {1, 2, 3} where '1', '2' and '3' 
represent the 3 categories: normal, early and moderate stage PD, respectively. 
2.5.1 Predictive modeling using Ordinal Logistic Regression 
The ordinal logistic regression (OLR) model (also called cumulative logit model or proportional 
odds model) is among the most popular methods for ordinal data analysis [31, 32]. As the 
number of categories is 3 in our study, there are 2 equations for the OLR model which are as 
follows:  
log 
𝑃 𝑦𝑖 ≤ 1 
𝑃 𝑦𝑖 > 1 
 = log  
𝜋1
𝜋2 + 𝜋3
 =  𝛼1 + 𝛽1𝑥𝑖
 1 + 𝛽2𝑥𝑖
 2 + ⋯+ 𝛽𝑚𝑥𝑖
 𝑚              1  
log  
𝑃 𝑦𝑖 ≤ 2 
𝑃 𝑦𝑖 > 2 
 = log  
𝜋1+𝜋2
𝜋3
 =  𝛼2 + 𝛽1𝑥𝑖
 1 + 𝛽2𝑥𝑖
 2 + ⋯+ 𝛽𝑚𝑥𝑖
 𝑚              (2) 
 where 𝛼1 and 𝛼2 are intercept parameters and satisfy 𝛼1 ≤ 𝛼2; and 𝛽 = [𝛽1,𝛽2,… ,𝛽𝑚 ] are the 
regression coefficients.  
2.5.2 Cost-sensitive Support Vector Machine (SVM) 
SVM is a powerful classification method that finds an optimal hyperplane (decision boundary) 
with the largest margin [33]. We use one-vs-one approach which is a competitive approach for 
multi-class classification [34]. This approach constructs 𝑘(𝑘 − 1)/2 classifiers, where each one 
is trained on two classes, for a k (in our case, k=3) class problem. For training data from classes i 
and j, the optimization problem is given by 
min
𝑤 𝑖𝑗 ,𝑏 𝑖𝑗 ,𝜉 𝑖𝑗
1
2
 𝒘𝑖𝑗  
𝑇
𝒘𝑖𝑗 + 𝐶  𝜉𝑖𝑗  
𝑡
𝑡
                                                 (3) 
subject to  
 𝑤𝑖𝑗  
𝑇
𝜑 𝒙𝑡 + 𝑏
𝑖𝑗 ≥ 1 −  𝜉𝑖𝑗  
𝑡
; if 𝑦𝑡 = 𝑖                                         (4) 
 𝑤𝑖𝑗  
𝑇
𝜑 𝒙𝑡 + 𝑏
𝑖𝑗 ≤ −1 +  𝜉𝑖𝑗  
𝑡
; if 𝑦𝑡 = 𝑗                                     (5) 
 𝜉𝑖𝑗  
𝑡
≥ 0                                                                  (6) 
For classification, a voting strategy is used: if 𝑠𝑖𝑔𝑛   𝑤𝑖𝑗  
𝑇
𝜑 𝒙 + 𝑏𝑖𝑗   indicates 𝒙 is in class i, 
then the vote for class i is increased by 1, else the vote for class j is increased by 1. 𝒙 is classified 
to the class which gets the largest vote. We use the radial basis function (RBF) kernel, given by 
𝐾 𝒙,𝒙𝑖 = exp −𝛾 𝒙 − 𝒙𝑖 
2 ;𝛾 > 0, for the SVM. 
 SVMs are believed to be less prone to the class imbalance problem, since boundaries between 
classes are calculated with respect to only a few support vectors and the class sizes may not 
affect the class boundary too much [29]. Nevertheless, we use a cost-sensitive approach with 
SVM where different penalty parameters are used for different classes, making errors on the 
minority instances costlier than the majority class instances. 
In our case, we employ GA for searching an optimal misclassification cost setup. Let 𝐶1,𝐶2 and 
𝐶3 denote the misclassification costs for the classes 1 (normal stage), 2 (early stage) and 3 
(moderate stage), respectively. The cost vector  𝐶1,𝐶2,𝐶3  which is encoded into the fitness 
function (which the GA optimizes). We have used the average F-measure (the mean of F-
measures of all the classes) as the fitness function for the GA. The final output of the GA is a 
vector which yields the most satisfactory performance among all tests. A brief description of the 
working of GA is given in Appendix B. 
2.5.3 Cost-sensitive AdaBoost-based classifier ensemble 
The AdaBoost (Adaptive Boosting) algorithm is an effective boosting algorithm which not only 
improves the classification accuracies of 'weak' learners, but is also an attractive technique for 
tackling the class imbalance problem. We use the multi-class extension of AdaBoost which is the 
AdaBoost.M2 algorithm as proposed by Freund and Schapire [35], for learning the weak learners 
(in our case, classification trees). The optimal cost (in our case,  𝐶𝑎𝑏1,𝐶𝑎𝑏2,𝐶𝑎𝑏3  where 𝐶𝑎𝑏𝑖  is 
the misclassification cost for class i) for each class is obtained using GA. The steps to create 
AdaBoost-based classifier ensemble is as follows: 
Input and Initialization 
1. Given the training set 𝑆 = { 𝒙𝑖 ,𝑦𝑖 }. 
 2. Let the number of iterations (which is the number of weak learners in the ensemble) be 
𝑇𝐴𝐵 . 
3. Let 𝐵 =  { 𝑖,𝑦 ;  𝑖 ∊  1,2,… ,𝑛 ,𝑦 ∊ 𝑌 − {𝑦𝑖} 
Algorithm 
1. Initialize the weight 𝐷1 𝑖, 𝑦 =
1
|𝐵|
 for (𝑖,𝑦) ∊ 𝐵 
2. for t = 1 to 𝑇𝐴𝐵  
a) Choose a weak learner, 𝑕𝑡 :𝑋 𝑌[0, 1], such that it minimizes pseudo-loss error 
given by 
𝑒𝑡 =
1
2
  𝐷𝑡(𝑖,𝑦) 1 − 𝑕𝑡 𝒙𝑖 ,𝑦𝑖 + 𝑕𝑡(𝒙𝑖 ,𝑦) 
𝑦≠𝑦𝑖
𝑛
𝑖=1
                                 (7) 
where 𝐷𝑡(𝑖,𝑦) contains observation weights at step 𝑡 for class 𝑦, 𝑕𝑡 𝒙𝑖 ,𝑦 ∊ [0,1] is the 
confidence of prediction of sample 𝒙𝑖  into class 𝑦 by the weak learner at step t, and 𝑦𝑖  is the true 
class. 
b) Compute the weight update parameter, 𝛽𝑡  given by 
 𝛽𝑡 =
𝑒𝑡
1−𝑒𝑡
                                                                          (8)  
c) Update the weight distribution using  
𝐷𝑡+1 𝑖,𝑦 =
𝐷𝑡 𝑖,𝑦 
𝑍𝑡
𝛽𝑡
1
2
 1+𝑕𝑡 𝒙𝑖 ,𝑦𝑖 −𝑕 𝒙𝑖 ,𝑦  
                                        (9) 
where 𝑍𝑡 =  𝐷𝑡(𝑖)𝑖  is the normalization constant. 
 3. Output the final hypothesis as  
𝑕𝐴𝐵 𝒙 = arg max
𝑦∊𝑌
  log
1
𝛽𝑡
 
𝑇𝐴𝐵
𝑡=1
𝑕𝑡 𝒙,𝑦                                            (10) 
The final hypothesis, 𝑕𝐴𝐵  outputs the label y, for an input instance 𝒙, that maximizes a weighted 
average of the weak hypothesis values 𝑕𝑡(𝒙,𝑦). 
2.5.4 RUSBoost-based classifier ensemble 
RUSBoost is a hybrid technique combining data sampling and boosting algorithm designed to 
improve performance of models on skewed data [25]. The data sampling used is random 
undersampling (RUS) technique in which it removes examples from the majority class at random 
until a desired class distribution is achieved. The sampling proportion which is required for 
RUSBoost algorithm is, often, unknown. We use GA to find a near optimal sampling proportion 
for each class (in our case  𝑝1,𝑝2,𝑝3  where 𝑝𝑖  is the sampling proportion for class i). If the 
sampling proportion leads to a value that is larger than the number of samples in a class, then 
RUSBoost samples the members with replacement, otherwise it samples the members without 
replacement. The steps to create a RUSBoost-based classifier ensemble are as follows: 
Input and Initialization 
1. Given the training set 𝑆 = { 𝒙𝑖 ,𝑦𝑖 }. 
2. Let the number of iterations (which is the number of weak learners in the ensemble) be 
𝑇𝑅𝑈𝑆  
 3. Let the proportion of samples in a training set after random undersampling be 
[𝑝1,𝑝2,… , 𝑝𝑘] by which the number of samples in class 𝑘 is 𝑝𝑘  times number of samples 
in the minority class. 
Algorithm 
1. Initialize the weights 𝐷1 𝑖 =
1
𝑛
 for all i. 
2. For t = 1 to 𝑇𝑅𝑈𝑆  
a) Create temporary training set 𝑆𝑡
′  with weight distribution 𝐷𝑡
′  using random 
undersampling. 
b) Choose a (any) weak learner which creates the hypothesis, 𝑕𝑡 :𝑋 𝑌[0, 1] when 𝑆𝑡
′  
and 𝐷𝑡
′  are passed to it. 
c) Compute the pseudo-loss error (based on original training set 𝑆 and weight 
distribution 𝐷𝑡 ) of 𝑕𝑡  using (7). 
d) Compute the weight update parameter 𝛽𝑡  using (8). 
e) Update the weight distribution 𝐷𝑡+1 using (9). 
3. Output the final hypothesis 𝑕𝑅𝑈𝑆  given by 
𝑕𝑅𝑈𝑆 𝒙 = arg max
𝑦∊𝑌
  log
1
𝛽𝑡
 
𝑇𝑅𝑈𝑆
𝑡=1
𝑕𝑡 𝒙,𝑦                                          (11) 
 
 
 2.5.5 k-Nearest Neighbor classifier  
From the input data, the k-nearest neighbor technique finds the k closest points for a test point 
and assigns the point to that class which is in majority [26]. The distance function used to 
estimate closeness is Euclidean. 
2.5.6 Probabilistic Generative Model 
In this approach, the conditional probability distribution 𝑃 𝑘 𝑥  is estimated in an inference 
stage, and then subsequently uses this distribution to make optimal predictions [28]. The 
optimization function is given by 
𝑦 = argmin
𝑦=1,2,3
 𝑃 𝑘 𝑥 𝐶 𝑦 𝑘 
3
𝑘=1
                                                   (12) 
where 𝑦  is the predicted class, 𝑃 𝑘 𝑥  is the posterior probability of class k for observation x, 
and 𝐶 𝑦 𝑘  is the cost of classifying an observation as y when its true class is k. 
The posterior probability 𝑃 𝑘 𝑥  is the product of the prior probability 𝑃(𝑘) and the class-
conditional densities 𝑃(𝑥|𝑘). Taking multivariate normal density as the conditional density, the 
density function of the multivariate normal with mean (μk) and covariance (Σ𝑘) at a point x is 
given by 
𝑃 𝑥 𝑘 =
1
(2𝜋 Σ𝑘  )0.5
exp −0.5 ∗  x − μk 
TΣk
−1 x − μk )                          (13)⁡ 
and the posterior probability 𝑃 𝑘 𝑥  is obtained by Bayes’ theorem given by 
𝑃 𝑘 𝑥 =
𝑃 𝑥 𝑘 𝑃(𝑘)
𝑃(𝑥)
                                                          (14)  
 The cost (or prior) could be optimally selected for imbalance class problems. For finding the 
optimal parameters, genetic algorithm was used.  
2.5.7 Neural Networks 
For the study, feedforward neural networks were used. For training is carried gradient descent 
algorithm with gradients computed via backpropagation [28]. The weight and bias update 
equations are given by 
𝑤𝑛𝑒𝑤 = 𝑤𝑜𝑙𝑑 − 𝜂
𝛿𝐿 𝑤, 𝑏 
𝛿𝑤
                                                       (15) 
𝑏𝑛𝑒𝑤 = 𝑏𝑜𝑙𝑑 − 𝜂
𝛿𝐿(𝑤, 𝑏)
𝛿𝑏
                                                       (16) 
Along with this, we also try with multilayer feedforward neural networks with 2 hidden layers 
which is a deep learning technique. The optimal number of neurons in the hidden layer is found 
using genetic algorithm. 
2.6 Estimation of feature importance in PD 
In our study, we estimate the importance of the features in a 2-class (PD/Normal) classification 
framework, by computing an importance score for these features. The technique used is the 
Random forests algorithm [27].  
The Random forests algorithm involves drawing n out of n observations with replacement which 
omits on average 37% of the observations for each decision tree. These constitute the 'out-of-bag' 
observations, and they can be used to estimate feature importance. An out-of-bag estimate of 
feature importance is obtained by randomly permuting out-of-bag data across one feature at a 
time, and estimating the increase in the out-of-bag error due to this permutation. The larger the 
 increase, higher the importance score of the feature. The out-of-bag error is estimated by 
comparing out-of-bag predicted responses and observed responses for all observations used for 
training. The Random forests algorithm is briefly described below: 
Input and Initialization 
1. Given the training set 𝑆 = { 𝒙𝑖 ,𝑦𝑖 }. 
2. Let the number of weak learners be 𝑇𝑅𝐹 . 
Algorithm 
1. for f = 1 to 𝑇𝑅𝐹  
a) Select a bootstrap sample [𝑋𝑓 ,𝑌𝑓] by randomly selecting n out of n observations with 
replacement from the training set S. 
b) Construct a decision tree 𝑇𝑓  from [𝑋𝑓 ,𝑌𝑓] by choosing a random subset of m' (where 
𝑚′ =  𝑚, in our case) from m features for every decision split, and recursively repeat 
this splitting for each terminal node of the tree until a minimum node size is reached. 
3. Output the ensemble of trees given by 𝑅𝑓 = {𝑇𝑓},𝑓 = 1, . .𝑇𝑅𝐹 . 
3. Results and Discussion 
3.1 Statistical testing of features 
The results of the statistical tests on the features are shown in Table 6 as shown below. It was 
observed that all 59 features are highly statistically significant, and thus are used for subsequent 
prediction modelling. 
 Table 6: Results of Kruskal-Wallis test and Wilcoxon rank sum test 
Sno Feature Abbrv. Chi-sq z-stat p-val* 
1 Cognitive impairment P1_COG 245.45 14.07 0.00 
2 Hallucination & Psychosis P1_HALL 95.10 8.96 0.00 
3 Depressed mood P1_DPRS 136.67 10.12 0.00 
4 Anxious mood P1_ANXS 118.56 10.56 0.00 
5 Apathy P1_APAT 218.67 13.53 0.00 
6 Features of DDS P1_DDS 65.09 5.65 0.00 
7 Sleep problems P1_SLPN 73.17 7.96 0.00 
8 Daytime sleepiness P1_SLPD 195.45 13.51 0.00 
9 Pain & other sensations P1_PAIN 147.11 11.86 0.00 
10 Urinary problems P1_URIN 296.58 16.51 0.00 
11 Constipation P1_CNST 391.59 19.54 0.00 
12 Light headedness P1_LTHD 267.03 14.62 0.00 
13 Fatigue P1_FATG 262.23 15.04 0.00 
14 Speech P2_SPCH 581.13 23.57 0.00 
15 Saliva & Drooling P2_SALV 488.27 21.27 0.00 
16 Chewing & Swallowing P2_SWAL 281.53 14.57 0.00 
17 Eating tasks P2_EAT 580.48 23.50 0.00 
18 Dressing P2_DRES 789.94 27.61 0.00 
19 Hygiene P2_HYGN 497.61 21.48 0.00 
20 Handwriting P2_HWRT 988.24 31.36 0.00 
21 Doing hobbies P2_HOBB 671.46 25.50 0.00 
 22 Turning in bed P2_TURN 499.88 21.85 0.00 
23 Tremor P2_TRMR 1467.90 38.80 0.00 
24 Getting out of bed P2_RISE 628.25 24.23 0.00 
25 Walking & Balance P2_WALK 677.54 23.61 0.00 
26 Freezing P2_FREZ 308.70 10.43 0.00 
27 Speech P3_SPCH 859.31 28.93 0.00 
28 Facial expression P3_FACXP 1768.92 41.97 0.00 
29 Rigidity neck P3_RIGN 910.68 29.98 0.00 
30 Rigidity Right Upper Extremity (RUE) P3_RIGRU 1220.12 35.25 0.00 
31 Rigidity Left Upper Extremity (LUE) P3_RIGLU 1063.47 32.75 0.00 
32 Rigidity Right Lower Extremity (RLE) P3_RIGRL 780.96 27.85 0.00 
33 Rigidity Left Lower Extremity (LLE) P3_RIGLL 695.42 25.70 0.00 
34 Finger tapping Right Hand (RH) P3_FTAPR 1179.13 34.50 0.00 
35 Finger tapping Left Hand (LH) P3_FTAPL 1026.36 31.81 0.00 
36 Hand movements RH P3_HMOVR 1017.20 31.93 0.00 
37 Hand movements LH P3_HMOVL 968.97 30.77 0.00 
38 PS movements RH P3_PRSPR 1044.02 32.62 0.00 
39 PS movements LH P3_PRSPL 913.79 30.14 0.00 
40 Toe tapping Right Foot (RF) P3_TTAPR 987.34 30.83 0.00 
41 Toe tapping Left Foot (LF) P3_TTAPL 897.83 29.43 0.00 
42 Leg Agility Right Leg (RL) P3_LGAGR 734.22 25.84 0.00 
43 Leg Agility Left Leg (LL) P3_LGAGL 704.55 25.65 0.00 
44 Arising from chair P3_RISNG 485.79 15.11 0.00 
 45 Gait P3_GAIT 1124.80 32.40 0.00 
46 Freezing of gait P3_FRZGT 160.15 5.36 0.00 
47 Postural stability P3_PSTBL 922.82 9.84 0.00 
48 Posture P3_POSTR 807.78 27.28 0.00 
49 Global spontaneity of movement P3_BRADY 1793.20 42.25 0.00 
50 Postural tremor RH P3_PTRMR 313.77 17.52 0.00 
51 Postural tremor LH P3_PTRML 304.04 16.76 0.00 
52 Kinetic tremor RH P3_KTRMR 252.58 15.78 0.00 
53 Kinetic tremor LH P3_KTRML 274.24 16.12 0.00 
54 Rest Tremor Amplitude (RTA) − RUE P3_RTARU 589.76 24.46 0.00 
55 RTA − LUE P3_RTALU 479.45 21.98 0.00 
56 RTA − RLE P3_RTARL 160.67 12.77 0.00 
57 RTA − LLE P3_RTALL 134.98 11.69 0.00 
58 RTA − Lip/jaw P3_RTALJ 80.15 9.12 0.00 
59 Constancy of rest tremor P3_RTCON 1127.34 33.80 0.00 
* All p-values were ≪ 0.01; Abbrv. is abbreviation. Chi-sq, z-stat and p-val stand for the Chi-
square statistic, value of the z-statistic and p-value. Here, as both Kruskal-Wallis test and 
Wilcoxon gave very low p-values for all features, only one column for p-value is shown. 
3.2 Logistic Model 
Table 7 shows the logistic model obtained from the complete data. This model shows no 
numerical problems, such as multicollinearity among the variables, as observed from the low 
standard errors (all SE's<2) for the regression coefficients.  
 The mean Brier score is obtained as 0.0242 which is very low indicating the closeness of 
probabilistic predictions with actual outcomes. The expected value of the class is computed 
which is used as an estimate of severity of PD in this study (formula is given in Appendix A). To 
provide a visual demonstration of the predictions from the logistic model, we plot the expected 
value of the class with the MDS-UPDRS total score (total from Parts I, II and III) and is shown 
in Fig. 5. We observe that the lower expected values correctly correspond to normal cases and 
the higher probabilities correctly correspond to PD. It is interesting to observe that 0.5 nicely 
seperates normal from early stage PD and 1.5 seperates moderate stage PD from early stage PD, 
as some clinicians use the modified version of the HY scale,  sometimes known under the 
designation “modified HY” which includes 0.5 increments.  
Table 7: The logistic model 
No. Features 𝛽 SE No. Features 𝛽 SE 
1. Cognitive impairment -0.2586 0.21 31. Rigidity LUE -0.6447 0.22 
2. Hallucination & 
Psychosis 0.5336 0.34 
32. Rigidity RLE 
-0.0697 0.21 
3. Depressed mood -0.0031 0.21 33. Rigidity LLE 0.0716 0.23 
4. Anxious mood 0.4439 0.20 34. Finger tapping RH -0.3170 0.23 
5 Apathy 0.1716 0.25 35. Finger tapping LH -0.0513 0.24 
6. Features of DDS* -0.0466 0.38 36. Hand movements RH 0.3249 0.25 
7. Sleep problems 0.1595 0.11 37. Hand movements LH 0.0811 0.27 
8. Daytime sleepiness -0.0970 0.13 38. PS movements RH -0.5399 0.23 
9. Pain & other sensations 0.0236 0.13 39. PS movements LH -0.4888 0.23 
10. Urinary problems -0.2205 0.14 40. Toe tapping- RF -0.4750 0.22 
 11. Constipation -0.3703 0.17 41. Toe tapping- LF 0.0258 0.20 
12. Light headedness -0.5029 0.18 42. Leg Agility- RL -0.0769 0.27 
13. Fatigue 0.1749 0.16 43. Leg Agility- LL 0.2351 0.25 
14. Speech -0.2895 0.19 44. Arising from chair 0.0540 0.27 
15. Saliva & Drooling -0.2749 0.13 45. Gait -1.0285 0.23 
16. Chewing & Swallowing -0.2342 0.25 46. Freezing of gait 1.2618 0.54 
17. Eating tasks 0.2484 0.25 47. Postural stability -3.4213 0.25 
18. Dressing -0.0440 0.28 48. Posture 0.5660 0.19 
19. Hygiene -0.3696 0.33 49. Global spontaneity of  
movement 
-1.3592 0.23 
20. Handwriting -0.6869 0.15 50. Postural tremor RH -0.0044 0.24 
21. Doing hobbies -0.1651 0.21 51. Postural tremor LH -0.1570 0.28 
22. Turning in bed 0.1648 0.27 52. Kinetic tremor RH 0.2299 0.27 
23. Tremor -1.0636 0.19 53. Kinetic tremor LH -0.3255 0.26 
24. Getting out of bed 0.7465 0.24 54. RTA − RUE 0.1879 0.21 
25. Walking & Balance -0.4961 0.20 55. RTA − LUE 0.0575 0.23 
26. Freezing 0.0769 0.32 56. RTA − RLE 0.3132 0.29 
27. Speech 0.1759 0.25 57. RTA − LLE -0.3221 0.40 
28. Facial expression -1.4895 0.21 58. RTA − Lip/jaw 0.2853 0.38 
29. Rigidity neck -0.0251 0.19 59. Constancy of rest tremor -0.9627 0.20 
30. Rigidity RUE -0.4709 0.19 
DDS−Dopamine Dysregulation Syndrome, PS− Pronation-Supination, RTA− Rest Tremor 
Amplitude, RUE−Right Upper Extremity, LUE−Left Upper Extremity, RLE−Right Lower 
Extremity, LLE−Left Lower Extremity, RH−Right Hand, LH−Left Hand, RL−Right Leg, 
 LL−Left Leg, RF−Right Foot, and LF−Left Foot. β is the regression coefficient for a predictor in 
the logistic model, SE is its standard error. The intercepts, α1 and α2, are obtained as 3.5843 and 
21.1390, respectively. The logistic model does not show any numerical instability as observed 
from the very low standard errors of the regression coefficients. 
 
Fig. 5. The plot of expected value of class with the sum of scores from MDS-UPDRS Parts I, II 
and III. It is observed that the higher expected values (which is the severity of the disease) rightly 
corresponded to the diseased cases and the lower values to the normal ones. 
We also estimate Spearman's rank correlation coefficients between a feature and the true stage 
(represented as R), and between a feature and the expected value of the class which is the 
predicted stage (represented as R'). Fig. 6 shows the values of R and R' for each feature. It is 
observed that R' for all features, except for the feature corresponding to sleep problems, is higher 
than R. The slightly lower R' for the sleep feature may be because, sleep disorders are very 
common among the elderly irrespective of PD. A large-scale study by Foley et al. [36], involving 
over 9000 elderly subjects, observed that around 57% reported at least one sleep problem 
(trouble falling asleep, waking up, awaking too early, needing to nap and not feeling rested). 
 This is also reflected in the feature severity plot as shown in Fig. 2, where we observe that the 
two most prominent features showing a sort of severity in normal stage population are the ones 
that are related to sleep (sleep problems and daytime sleepiness).  
 
Fig. 6. Plot of correlation of features with original stage and with the predicted stage which is the 
expected value of the class variable. Almost all the features showed higher correlation with the 
expected value than with the original stage. 
Tremor (P2_TRMR, feature no. 23), loss of facial expression or hypomimia (P3_FACXP, feature 
no. 28) and global spontaneity of movement or body bradykinesia (P3_BRADY, feature no. 49) 
were among the most correlated features with the stage, which is consistent with the clinical 
perspective of the disease [2]. When we observe the most correlated features with the expected 
value of the class, gait (P3_GAIT, feature no. 45) also shows higher importance along with these 
3 features. This higher correlation of gait feature may be because, to evaluate this item in the 
MDS-UPDRS (testing of gait), it involves walking of the patient away from and towards the 
examiner, and involves measurement of multiple behaviors: stride amplitude, stride speed, height 
of foot lift, heel strike during walking, turning, and arm swing, but not freezing, which may have 
 correlation with other features in the MDS-UPDRS. Gait disturbances such as freezing of gait 
(P3_FRZGT, feature no. 46) showed a very low correlation with both the stage and the expected 
value of the class (both R and R') which is consistent with previous studies which suggest that 
these conditions usually occur in advanced PD [37]. 
Overall, the logistic model performed well as observed from the very low Brier score indicating 
that lower probabilities correctly corresponded to normal observations and higher probabilities 
correctly corresponded to PD cases, and higher Spearmen's rank correlation of features with the 
expected value of the class than with the true category. 
3.3 Cost and sampling proportion estimation using GA 
Genetic algorithm (GA) is used to estimate near optimal costs for SVM and AdaBoost-based 
ensemble, RUSBoost-based ensemble, Random forests, probabilistic generative model, neural 
networks (also deep learning). The fitness function used for the GA is the average F-measure of 
the 3 classes. The other options used for GA are as follows: Crossover fraction as 0.8, elite count 
as 2 for both SVM and AdaBoost-based ensemble, and 8 for RUSBoost-based ensemble, 
mutation function is such that it randomly generates directions that are adaptive with respect to 
the last successful or unsuccessful generation, and the number of generations is set as 50. The 
initial population range was carefully chosen based on empirical experiments.  
Fig. 7 shows the plots for the genetic algorithm based parameter selection for different 
classifiers. We can observe that generally mean errors and least error in a population decreases 
with iteration, except for RUSBoost, Random forests, Neural Networks and Deep learning 
methods. For RUSBoost and Random forests, it is due to the inherent sampling involved in these 
methods and for neural networks and deep learning, it is due to the non-convex optimization 
 which leads to different convergences for different initializations. Fig. 7 also shows the mean 
error from the population along with the error for the best individual. The difference between the 
error from the best individual and other members in the population are the following: for 
Adaboost it is 0.0119, for RUSBoost it is 0.0308, for Random forests it is 0.0196, for SVM it is 
0, for probabilistic generative model, it is 0, for neural networks it is 0.024, and for deep learning 
it is 0.032. The error of 0 means all the members in the present generation are same. 
 
(a) AdaBoost 
 
(b) SVM 
  
(c) RUSBoost 
 
(d) Random forests 
 
(e) Probabilistic generative model 
  
(f) Neural Networks 
 
(g) Deep Learning 
Fig. 7.  Plots for the genetic algorithm based parameter selection for different classifiers. (a) 
Adaboost (b) SVM (c) RUSBoost (d)Random forests (e) Probabilistic generative model (f) 
Neural networks (g) Deep Learning 
We used LIBSVM [30] library for implementing cost-sensitive SVM which had 5 parameters to 
be estimated: the cost 𝐶 of SVM, 𝛾 for the RBF kernel, parameters 𝐶1,𝐶2,𝐶3 for the three classes 
which are multiplied with 𝐶 which forms the misclassification costs for the 3 classes. The values 
obtained for 𝐶, 𝛾,𝐶𝑠𝑣𝑚1,𝐶𝑠𝑣𝑚2 and 𝐶𝑠𝑣𝑚3 are 33.0416, 0.0355, 2.0, 1.0  and 2.7733, respectively.  
 The AdaBoost-based ensemble had 4 parameters to be estimated: the misclassification costs 
𝐶𝑎𝑏1,𝐶𝑎𝑏2,𝐶𝑎𝑏3 for the 3 classes, and the number of weak learners 𝑇𝑎𝑏 . The optimal values for 
𝐶𝑎𝑏1,𝐶𝑎𝑏2,𝐶𝑎𝑏3 and 𝑇𝑎𝑏  obtained using GA are 1.3651, 1.0003, 2.6583and 117, respectively. 
Likewise in SVM, the cost for the moderate stage PD class is higher than the other 2 classes. 
The RUSBoost-based ensemble had 4 parameters to be estimated: the sampling proportions 
𝑝𝑟𝑢𝑠1,𝑝𝑟𝑢𝑠2,𝑝𝑟𝑢𝑠3 for the 3 classes, and the number of weak learners 𝑇𝑟𝑢𝑠 . The values for 
𝑝𝑟𝑢𝑠1,𝑝𝑟𝑢𝑠2,𝑝𝑟𝑢𝑠3,𝑇𝑟𝑢𝑠   were obtained as 2.0781, 9.3262, 1.5190 and 47 , respectively. The 
sampled training set contains highest number of examples from the early PD category. 
The Random forests had 4 parameters to be estimated: the misclassification costs 𝐶𝑟𝑓1,𝐶𝑟𝑓2,𝐶𝑟𝑓3 
for the 3 classes, and the number of weak learners 𝑇𝑟𝑓 . The near optimal values for 
𝐶𝑟𝑓1,𝐶𝑟𝑓2,𝐶𝑟𝑓3 and 𝑇𝑟𝑓  obtained using GA are 2.3732, 12.4722, 1.3256 and 51, respectively. 
The probabilistic generative model had 3 parameters to be estimated: the misclassification costs 
𝐶𝑝𝑔𝑚 1,𝐶𝑝𝑔𝑚 2,𝐶𝑝𝑔𝑚 3 for the 3 classes which were obtained as 598.72, 5724.99 and 28.88, 
respectively 
Neural networks had one parameter to be estimated which was the number of hidden neurons 
(𝑛𝑕1) in the hidden layer which was obtained as 30. And for the multi-layered neural network 
(deep learning), there were two hidden layers and the number of neurons in these layers 
[𝑛𝑕1 ,𝑛𝑕2] were estimated as [100, 38].  
3.4 Predictive modeling and performance comparison of models 
'Classification trees' is used as the 'weak learners' for developing AdaBoost-based ensemble, 
RUSBoost-based ensemble, and Random forests. The minimum size of the leaf node for a tree is 
 taken as 1. Table 8 shows the average performance measures (overall accuracy, precision, recall, 
and F-measure) for the classifiers. The AdaBoost-based ensemble, Random forests, SVM and 
Probabilistic generative model gave very high performances as indicated by the accuracies and 
F-scores. Logistic regression gave relatively a lower accuracy and F-score indicating the non-
linearity involved in the data.  
Table 8: Performance metrics of the classifiers used 
 Normal Early Moderate 
Classifier Acc Prec Recall F-scr Prec Recall F-scr Prec Recall F-scr 
SVM 96.84 96.66 98.66 97.65 98.04 97.07 97.55 74.08 72.37 73.21 
AdaBoost 97.46 98.32 97.98 98.15 97.14 98.96 98.04 93.40 61.06 73.85 
RUSBoost 96.29 96.51 98.61 97.55 98.59 95.65 97.10 61.13 84.02 70.77 
RF 97.13 98.63 97.06 97.84 96.80 98.79 97.78 85.05 63.76 72.89 
LR 95.63 96.15 96.63 96.39 96.47 96.64 96.56 70.42 63.92 67.02 
k-NN 95.56 95.22 98.69 96.93 96.87 96.15 96.51 65.21 49.27 56.13 
PGM 96.38 96.06 97.54 96.80 97.86 96.60 97.23 72.05 79.06 75.40 
NB 90.98 84.72 98.74 91.19 96.91 88.70 92.62 56.93 53.43 55.13 
NN 96.73 96.81 98.13 97.46 97.26 97.70 97.48 81.20 61.54 70.01 
DL 96.69 97.11 97.96 97.53 97.09 97.81 97.45 79.52 59.92 68.35 
* All values in percentage. Acc, Prec and F-scr stands for accuracy, precision and F-score. SVM, 
AdaBoost, RUSBoost, RF, LR, k-NN, PGM, NN and DL stand for Support vector machine, 
 AdaBoost based ensemble. RUSBoost based ensemble, Random forests, Logistic regression, k-
nearest neighbor, Probabilistic generative model, Neural network and Deep learning, 
respectively. 
3.5 Error Analysis 
To visualize the misclassified instances, we use the total of the scores from the Parts I, II and III 
of the MDS-UPDRS (sum of all 59 features) as the variable for plotting. Fig. 8 shows the box 
plot of the full data used in the study and the box plots of the observations which were 
misclassified by the high performing classifiers. From these box plots, we can observe that only 
those observations which did not follow a pattern were misclassified. Looking at the box plot of 
full data, it can be observed that the median total score of the normal group is much lower than 
the early stage group.This pattern is violated for the misclassified instances as observed from the 
box plots of the misclassified instances.  
For instance, when we look at the misclassified instances from SVM, AdaBoost ensemble and 
Random forests, the median value of the total score of the misclassified early observations were 
much lower than the median value of the misclassified normal observations.  
Normal stage observations with higher MDS-UPDRS scores were misclassified as early stage 
cases (but not as moderate stage) by the classifiers. Early stage observations with lower MDS-
UPDRS scores were misclassified as normal, and with higher MDS-UPDRS scores were 
misclassified as moderate stage (this was very low in number). And misclassifications of 
moderate stage as normal or early stage also occurred in a similar manner. The spread of the 
misclassified moderate stage instances is similar for all the classifiers. 
 Most of the misclassifications occurred between early stage and moderate stage PD classes. This 
is because the severity of symptoms (or the features) in moderate PD is not severe, unlike in 
advanced PD, and due to which a good amount of overlap exists between the features for these 
two classes. This is also reflected in Fig. 2. 
 
(a) Full data 
 
(b) AdaBoost 
 
(c) SVM 
 
(d) Random forests 
  
(e) Probabilistic generative model 
 
(f) Logistic regression 
Fig. 8.  Box plots of full data and of misclassified instances from few classifiers used in the study 
(a) box plot of full data (b) AdaBoost-based ensemble (c) SVM (d) Random forests (e) 
probabilistic generative model and (f) Logistic regression. 
3.6 Feature importance estimation in PD 
In case of 2-class classification, all 59 features are observed to be statistically significant (p-
value<0.05) based on Wilcoxon rank sum test. Hence, all 59 features are used for subsequent 
feature importance estimation using Random forests.  
The plot of feature importance is shown below in Fig. 9. Global spontaneity of movement 
(P3_BRADY), tremor (P2_TRMR), loss of facial expression (P3_FACXP), constancy of rest 
tremor (P3_RTCON)  and handwriting or micrographia (P2_HWRT) were observed to be the 
most important features which is consistent with the clinical perspective of the disease [2]. 
Global spontaneity of movement and rest tremor are clinically, the most common and easily 
recognized symptoms of PD [2]. During the evaluation of global spontaneity of movement rating 
in the MDS-UPDRS, all observations on slowness, hesitancy, and small amplitude and poverty 
 of movement in general, including a reduction of gesturing and of crossing the legs, is taken into 
account. This assessment is based on the examiner's global impression after observing 
spontaneous gestures while sitting, and the nature of arising and walking [5]. Loss of facial 
expression is also a form of bradykinesia that involves facial muscles. Constancy of rest tremor 
is evaluated based on one rating for all tremors (RUE−Right Upper Extremity, LUE−Left Upper 
Extremity, RLE−Right Lower Extremity, LLE−Left Lower Extremity and Lip/Jaw) during the 
examination period, when different body parts are variously at rest [5]. In the early stages of PD, 
gait is characterized mainly by reduced speed and decreased amplitude of leg movements, 
accompanied by reduced arm swing. From Fig. 9., gait (P3_GAIT) is observed as a feature of 
moderate importance. Falls and complex gait disturbances such as freezing and start hesitations 
are usually confined to the later stages of PD [37]. Our result (that the feature freezing of gait as 
the least important feature) is consistent with this as we do not involve samples from late stage 
PD.  
Along with this, a plot showing the difference between percentages of observations showing 
severity in HC and PD groups is also given below in Fig. 10. Comparing these graphs, we can 
observe that the highest raked features, from the Random forests technique, such as P2_TRMR 
(Tremor), P3_FACXP (Facial expression), P3_BRADY (Bradykinesia or Global spontaneity of 
movement), P3_RTCON (Constancy of rest tremor), also had higher difference of percentages of 
observations showing severity in HC and PD groups. In Fig. 10, we can observe that P3_FACXP 
and P3_BRADY have similar difference of percentages. It is to be noted that both these features 
had strong correlation of 0.76 as compared to other correlations between features, and because of 
this correlation, one of the features, which in our case P3_BRADY had lower importance 
estimate as compared to the P3_FACXP from the Random forests technique.   
 For features from 7-13, they evaluate the non-motor aspects of experiences in daily life and they 
were filled by the patient themselves. Studies have shown that age is a crucial factor for 
influencing non-motor features and as the dataset involves mostly aged cohort, the age factor 
might have played crucial role in increasing the score for these features in the HC group. And 
these features had lower importance estimates from the Random forests model as observed from 
the Fig. 9. Although these features showed lower importance, they are certainly important and 
are highly statistically significant. 
The Random forests model which was used to estimate the feature importance gave an accuracy 
of 99.03%, sensitivity of 99.51% and specificity of 98.10% indicating its high performance in 
distinguishing PD from HC. The average confusion matrix is as shown below in Table 9. It can 
be observed that the number of PD observations which were not detected was very low (which is 
10 or 0.5%) indicating that the machine learning model might was able to learn the complex 
patterns in the data which helped in the detection. 
 
Fig. 9. Plot of feature importance scores using Random forests 
  
Fig. 10. The plot of difference of percentages of observations showing severity in PD and HC 
groups 
Table 9: Confusion matrix obtained from the Random forests model for the 2-class case 
 Predicted 
PD HC 
True 
PD 1985 10 
HC 19 1006 
 
3.7 A note on cost-sensitive and sampling based imbalanced data learning used in the study 
The imbalance of data used is of extrinsic type. The imbalance is not directly related to the 
nature of the data space. We tried with the default costs and sampling proportions (i.e., assigning 
misclassification costs and sampling proportions as 1 for all classes) for SVM, AdaBoost-based 
ensemble and RUSBoost-based ensemble. It is observed that the SVM and AdaBoost ensemble 
gave almost similar performance as compared to the cost-sensitive versions. This finding is 
 consistent with the study by Japkowicz and Stephen [38], where they observe that SVMs are less 
sensitive to the class imbalance problem. On the other hand, the AdaBoost algorithm is an 
approach which inherently performs a weighting strategy that is equivalent to re-sampling the 
data space, combining both up-sampling and down-sampling. When the learning is proper, this 
re-sampling can avoid extra cost estimation for exploring the optimal class distribution [23].  
3.8 Note on using a combined data from different patients 
The course or progression of PD is not linear and it varies between subjects. And this fact is 
established by many research studies. In this way, the combined dataset might become complex 
with different kinds of patterns in it. And this was one of the main motivation for using machine 
learning techniques on this data as it is established that these techniques have the potential to 
learn the latent (or hidden) information from the data and can effectively use it in prediction. 
And from our study, we observe that we obtain high performance in estimating the stage of a 
subject as indicated by the accuracy and other performance measures. It is also observed that the 
learned stage or the expected value of the class variable from the logistic models showed higher 
correlation with the features, as shown on Fig. 6 shown below, indicating its usefulness. 
Furthermore, rather than using a generalized model for prediction, patient specific models can be 
developed which might have higher performance and usefulness. But for this, a large amount of 
data for each subject has to be collected which is a limitation for patient specific models. 
3.9 Limitations and future work 
Our study used only samples corresponding to normal, early and moderate stage PD, and did not 
consider advanced PD due to unavailability of data. However, the approach used in the study is 
applicable while learning data involving advanced (or late) stage PD also. This is because there 
 is severe deterioration of symptoms in advanced stages of PD leading to significant separation 
between class distributions. Testing these approaches in an extended dataset involving advanced 
PD observations is a possible future goal. Along with this, another interesting future study would 
be consider data from a single visit such as visit at month 60 (V12), to provide further 
restrictions on the timelines of data collections, for the analysis. However such an analysis could 
make the data further imbalanced which needs to be addressed appropriately. 
Our study also had limited number of moderate stage PD samples. This is an example of 
extrinsic imbalance [21] where the imbalance is not a direct result of the nature of the data space. 
(The PPMI database has limited observations from moderate stage PD). The Random forests 
technique, due to its unique 'out of bag' property, can be an ideal tool to estimate feature 
importance. We estimated the feature importance in PD, and not corresponding to the stages of 
PD because moderate stage PD observations were low in number, and the feature importance 
scores from Random forests is based on the out-of-bag error estimates which is biased towards 
the majority classes. Estimation of feature importance between stages is another possible future 
work. 
4. Conclusion 
Although there is no cure for PD yet, there are a variety of treatments that can help a patient lead 
a fulfilling and productive life for many years. The therapeutic options depend on the stage and 
severity of PD. MDS-UPDRS is a widely used rating scale evaluating the severity of most 
pertinent features of PD. In this study, we propose a novel staging for PD using MDS-UPDRS 
features, HY scale, combined with classifiers that can be effective tools to estimate the stage and 
 severity of PD. Such tools can aid in detection and diagnosis, and thereby, helping in taking 
effective therapeutic decisions in PD. 
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 Appendices 
A. Performances measures 
Performance measures play a crucial role in both evaluating the classification performance and 
guiding the classifier modelling. We have used four measures to evaluate the performance of 
classifiers: Accuracy, Precision, Recall and F-measure. 
𝐴𝑐𝑐𝑢𝑟𝑎𝑐𝑦 =
𝑇𝑃 + 𝑇𝑁
𝑇𝑃 + 𝑇𝑁 + 𝐹𝑃 + 𝐹𝑁
 
𝑃𝑟𝑒𝑐𝑖𝑠𝑖𝑜𝑛 =
𝑇𝑃
𝑇𝑃 + 𝐹𝑃
 
𝑅𝑒𝑐𝑎𝑙𝑙 =
𝑇𝑃
𝑇𝑃 + 𝐹𝑁
 
𝐹 −𝑚𝑒𝑎𝑠𝑢𝑟𝑒 =
2𝑃𝑟𝑒𝑐𝑖𝑠𝑖𝑜𝑛𝑅𝑒𝑐𝑎𝑙𝑙
𝑃𝑟𝑒𝑐𝑖𝑠𝑖𝑜𝑛 + 𝑅𝑒𝑐𝑎𝑙𝑙
 
where TP is true positive, TN is true negative, FP is false positive and FN is false negative. 
Accuracy is measured as an overall estimate, whereas, Precision, Recall and F-measure are 
computed for each class. The average F-measure for the 3 classes is chosen as the fitness 
function, for GA, as it gives equal importance to all classes.  
Along with these, we also compute the Brier score for evaluating the logistic model, given by 
𝐵𝑟𝑖𝑒𝑟 𝑠𝑐𝑜𝑟𝑒 =
1
𝑛𝑘
   𝑝 𝑖, 𝑗 − 𝑝 (𝑖, 𝑗) 2
𝑘
𝑗=1
𝑛
𝑖=1
 
 where 𝑝 𝑖, 𝑗  and 𝑝 (𝑖, 𝑗) are true and estimated probability of observation i to belong to class j; k 
is the number of classes (in our case 3), and n is the number of observations. The expected value 
of the class is used as a measure of severity of PD in the study. It is given by 
𝐸 =  (𝑗 − 1)
𝑘
𝑗=1
𝑝 (𝑖, 𝑗) 
(𝑗 − 1) is used instead of j to ensure that probabilities of early and moderate stage PD are used in 
the severity estimation. 
B. Genetic Algorithm for optimal cost and sampling proportion estimation 
Genetic algorithm (GA) is a method for solving optimization problems and is based on the 
theory of natural selection. The two main concepts in GA are 1) Fitness function, and 2) 
Individuals. Fitness function is the function that is to be optimized, and an individual is any 
vector (which can also be the solution to the fitness function) that contains the values of variables 
of the fitness function. The fitness function used for GA is the average F-measure of the 3 
classes. 
 A brief outline of the working of GA is given below: 
1) The algorithm begins with an initial population (which can be a random population or a 
population created from a specified range). A population is a set of individuals. 
2) It then creates a sequence of new populations based on the current population. To create a 
new population from the current population, the algorithm performs the following: 
a) A fitness score is computed for each member in the current population. 
 b) Few of the individuals that have lower fitness values, as compared to others, are chosen 
as elite, and are passed to the next generation. 
c) Selects members (called parents) based on their fitness values. Parents are expected to 
have better fitness values.  
d) It, then produces children from the parents either by crossover (by combining two 
parents) or mutation (by making random changes to a single parent). 
e) Replaces the current population with the new population consisting of elite children, 
crossover children and mutation children. 
The process of creating a new population is repeated till the stopping criteria is met. 
C. Progression of features with time 
Fig. C1 shows the progression of all 59 features with time. All the features showed significant 
variation in PD as compared to healthy control. 
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Fig. C1. The plot of average severity of features for HC and PD for different visits. The visit at 
month 84 (V14) was not included in the plots as the number of observations for V14 were very 
low. 
 
 
